Overview
Myasthenia Gravis Plasma | High-Quality Human Plasma from Myasthenia Gravis (MG) Donors
Myasthenia Gravis Plasma is collected from donors clinically diagnosed with Myasthenia Gravis (MG) and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in MG pathophysiology.
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed MG donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
Donor Metadata
- Verified MG diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional Myasthenia Gravis (MG)-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Myasthenia Gravis plasma is available in standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.